Regeneron Pharmaceuticals, Inc.
Tropism-Modified Recombinant Viral Vectors and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells
Last updated:
Abstract:
Provided herein are compositions and methods for retargeting recombinant viral capsid proteins/capsids/vectors, e.g., in vivo, with a multispecific binding molecule, such as a bispecific antibody, that specifically binds a heterologous epitope displayed by the capsid protein and a protein expressed on the cell of interest for the targeted delivery of a nucleotide of interest.
Status:
Application
Type:
Utility
Filling date:
27 Jun 2018
Issue date:
7 May 2020